Alliance A071701 (Brain Metastases)

What is the Purpose of this Study?

If you choose to join this study, you will:
- Have blood draws
- Have EKG's (a way to measure your heart activity)
- Take the 1 of the 3 study drugs that is assigned to your specific cancer
-- The 3 types of medication are Abemaciclib, GDC-0084, and Entrectinib.)
- Keep a pill diary (to help track when you take your pills)
What is the Condition Being Studied?
Brain Metastases

Who Can Participate in this Study?

Adults diagnosed with brain metastases

Age Group
Adults
Participating Institutions

What is Involved?

We are doing this study to learn more about the side effects of the study drug and to determine if it will help shrink the cancer by at least 30%.

Study Details

Full Title
Alliance A071701: Genomically-Guided Treatment Trial in Brain Metastases
Principal Investigator

Contacts
Tisch Brain Tumor Center DCI Clinical Research Team
Protocol Number
IRB:
PRO00104080

NCT:
NCT03994796
ClinicalTrials.gov
View on ClinicalTrials.gov